PLx Pharma Appoints CEO
This article was originally published in Scrip
PLx Pharma Inc. has appointed Natasha Giordano CEO replacing Ronald R. Zimmerman, who will remain on the company's board of directors and continue in his role as founder and senior advisor. Giordano has also been appointed president and member of the board and brings over 25 years' experience to the company. Before PLx, she was president and CEO of Clear Point Learning and prior to this she held the same positions at Healthcare Corporation of America. Previously, Giordano was also president and CEO of Xanodyne Pharmaceuticals.